PERSEUS BIDCO UK LTD

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  -10%

  £108,716,000 → £97,843,000

• Cash

  -11.2%

  £12,223,000 → £10,849,000

• Net assets

  +7.1%

  £229,635,000 → £245,861,000

• Employees

  +0.6%

  168 → 169

• Operating profit

  +14.7%

  £34,955,000 → £40,086,000

• Profit before tax

  -4.6%

  £32,539,000 → £31,053,000

• Wages

  +0.9%

  £11,097,000 → £11,200,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

IFRS

Reporting scope

Consolidated group

Auditor

Kreston Reeves Audit LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“Based on their assessment, the directors believe that the Group will continue to be able to meet its liabilities as they fall due for the foreseeable future and accordingly have prepared the consolidated financial statements on a going concern basis.”

Group structure

1. PERSEUS BIDCO UK LTD · parent
   1. Protherics Medicines Development Limited 100% · England and Wales · Development, management and commercialisation of pharmaceutical Intellectual Property Rights
   2. Protherics UK Limited 52% · England and Wales · Research, development, manufacture and sale of pharmaceutical products

Significant events

• “During the year, the Company cancelled its Share premium of £106,266,000, crediting this amount to Retained earnings, and received forgiveness of Borrowings of £320,151,000 that were previously owing to its subsidiaries. This returns the Company to a net assets position.”
• “During the year, Protherics UK Limited recognised a charge of £254,072,000 resulting from the forgiveness of promissory loan notes and associated interest previously due from the Company.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

12

last 12 months

Capital events

2

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.